Search

everythinglearnresearchcommunity

for

Search:↓

New regenerative treatments for hair loss show promise but need more research for confirmation.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Oral minoxidil is effective for various hair loss types and may improve male sexual function, but aspirin can reduce its effectiveness.

New treatments for male pattern hair loss look promising, but established treatments are still the main option.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Testosterone in human pancreas cells boosts insulin production.

Changes in early neurosteroid levels can affect adult learning and anxiety.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Androgen increases VEGF expression but not VEGFR-2 in rat corpus cavernous.

Pregnant female urologists should avoid certain drugs and use protective measures to stay safe.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Stress increases neurosteroids that help prevent seizures.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Massaging the scalp with a cosmetic containing certain natural inhibitors can significantly regrow hair in men with pattern baldness.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Dermatologists should address erectile dysfunction in patients with skin conditions to improve their quality of life.

DHT increases scalp heat, causing hair loss.

DHT increases scalp heat, causing hair loss.